Pharmacogenomic Assessment of Outcomes of Pemetrexed-Treated Patients with Adenocarcinoma of the Lung

PURPOSE: The main objective of this study was to evaluate the association between polymorphisms of the target genes of pemetrexed and clinical outcomes in non-small cell lung cancer (NSCLC) patients treated with pemetrexed. MATERIALS AND METHODS: We assessed polymorphisms at 8 sites in 4 genes [thym...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jung, Minkyu, Lee, Chul Ho, Park, Hyung Soon, Lee, Ji Hyun, Kang, Young Ae, Kim, Se Kyu, Chang, Joon, Kim, Dae Joon, Rha, Sun Young, Kim, Joo Hang, Cho, Byoung Chul
Formato: Artigo
Lenguaje:Inglês
Publicado: Yonsei University College of Medicine 2013
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3663241/
https://ncbi.nlm.nih.gov/pubmed/23709418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2013.54.4.854
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares